Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Safety, Tolerability and Pharmacokinetics Study of CDD-2101 in Health Volunteers

NCT06570668 is registered in ClinicalTrials.gov with Centre for Chinese Herbal Medicine Drug Development Limited as lead sponsor.

NCT NCT06570668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06570668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Safety, Tolerability and Pharmacokinetics Study of CDD-2101 in Health Volunteers
Lead sponsor
Centre for Chinese Herbal Medicine Drug Development Limited
Phase
Phase 1
Overall status
Completed
Start date
May 29, 2024
Completion date
July 12, 2024
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

constipation - functional